Amedisys Stock Insider Trading

Healthcare > Medical - Care Facilities

Buy AMED

*Your capital is at risk

$100.99

+0 (+0%)

At Close: Nov 13, 2025

Amedisys Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -40.81. In total, the insiders bought 208.21K and sold 14.79M AMED shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-40.81
● Buy	208.21K shares
● Sell	14.79M shares
14% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Aug 14, 2025 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -40.81. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 14, 2025 Buy	Common Stock M-Exempt	Ginn Scott G EVP, CFO & COO	C-Suite Officer	10 399 Value: $1.05M
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Griffin Jennifer G Chief Legal Officer	Officer	496 Value: $130.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Griffin Jennifer G Chief Legal Officer	Officer	563 Value: $120.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Griffin Jennifer G Chief Legal Officer	Officer	640 Value: $84.7K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Griffin Jennifer G Chief Legal Officer	Officer	327 Value: $31.3K
Aug 14, 2025 Sell	Common Stock D-Return	Griffin Jennifer G Chief Legal Officer	Officer	341 Value: $0
Aug 14, 2025 Sell	Common Stock D-Return	Griffin Jennifer G Chief Legal Officer	Officer	10 700 Value: $11
Aug 14, 2025 Sell	Common Stock D-Return	Capps Vickie L Director	Director	9 818 Value: $10
Aug 14, 2025 Sell	Common Stock D-Return	Kline Teresa L. Director	Director	9 818 Value: $10
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Muscato Nick Chief Strategy Officer	Officer	2 876 Value: $263.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Muscato Nick Chief Strategy Officer	Officer	2 040 Value: $292.2K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Muscato Nick Chief Strategy Officer	Officer	708 Value: $186.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Muscato Nick Chief Strategy Officer	Officer	563 Value: $120.9K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Muscato Nick Chief Strategy Officer	Officer	320 Value: $42.4K
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Muscato Nick Chief Strategy Officer	Officer	272 Value: $26.0K
Aug 14, 2025 Buy	Restricted Stock Unit (Performance-Based Vesting) M-Exempt	Muscato Nick Chief Strategy Officer	Officer	3 468 Value: $350.2K
Aug 14, 2025 Sell	Common Stock D-Return	Muscato Nick Chief Strategy Officer	Officer	212 Value: $0
Aug 14, 2025 Buy	Common Stock M-Exempt	Muscato Nick Chief Strategy Officer	Officer	3 468 Value: $350.2K
Aug 14, 2025 Sell	Common Stock D-Return	Muscato Nick Chief Strategy Officer	Officer	3 067 Value: $3
Aug 14, 2025 Sell	Common Stock D-Return	Rideout Jeffrey A Director	Director	9 335 Value: $9
Aug 14, 2025 Sell	Stock Option (Right to Buy) D-Return	Kusserow Paul B. K. Director	Director	80 602 Value: $9.25M
Aug 14, 2025 Sell	Common Stock D-Return	Kusserow Paul B. K. Director	Director	621 Value: $0
Aug 14, 2025 Sell	Common Stock D-Return	Kusserow Paul B. K. Director	Director	439 124 Value: $439
Aug 14, 2025 Sell	Common Stock D-Return	Klapstein Julie D Director	Director	16 031 Value: $16
Aug 14, 2025 Sell	Common Stock D-Return	Coye Molly Joel Director	Director	8 818 Value: $9

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AMEDISYS INC

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitatio...

Read Full Profile Here